Evidence map›Paper›PMID 35015787›Full record

ArticlePloS one2022

Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.

Yuhua Zhang, An O Van Laer, Catalin F Baicu, Lily S Neff, Stanley Hoffman, Marc R Katz, Sanford M Zeigler, Michael R Zile, Amy D Bradshaw

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Mechanical stretch reduces fibroblast activation in heart failure with reduced ejection fraction.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuhua ZhangDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
An O Van LaerDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Catalin F BaicuDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Lily S NeffDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Stanley HoffmanDivision of Rheumatology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Marc R KatzDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Sanford M ZeiglerDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina, United States of America.ORCID 0000-0001-8634-7133
Michael R ZileDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Amy D BradshawDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Medical University of South Carolina · US

Funding

Cellular, Biochemical and Molecular Sciences Training Program: Developing the skills and expertise needed for a changing biomedical landscapeT32GM132055 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Amy D Bradshaw, John P O'Bryan · 2019 to 2026
$3.9M
Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart FailureR01HL123478 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ZILE, MICHAEL R · 2015 to 2018
$1.5M
CSRD VA I01 CX001608NHLBI NIH HHS R01 HL123478NIGMS NIH HHS T32 GM132055
6 · The paper itself

Abstract

Heart failure is a leading cause of hospitalizations and mortality worldwide. Heart failure with a preserved ejection fraction (HFpEF) represents a significant clinical challenge due to the lack of available treatment modalities for patients diagnosed with HFpEF. One symptom of HFpEF is impaired diastolic function that is associated with increases in left ventricular stiffness. Increases in myocardial fibrillar collagen content is one factor contributing to increases in myocardial stiffness. Cardiac fibroblasts are the primary cell type that produce fibrillar collagen in the heart. However, relatively little is known regarding phenotypic changes in cardiac fibroblasts in HFpEF myocardium. In the current study, cardiac fibroblasts were established from left ventricular epicardial biopsies obtained from patients undergoing cardiovascular interventions and divided into three categories: Referent control, hypertension without a heart failure designation (HTN (-) HFpEF), and hypertension with heart failure (HTN (+) HFpEF). Biopsies were evaluated for cardiac myocyte cross-sectional area (CSA) and collagen volume fraction. Primary fibroblast cultures were assessed for differences in proliferation and protein expression of collagen I, Membrane Type 1-Matrix Metalloproteinase (MT1-MMP), and α smooth muscle actin (αSMA). Biopsies from HTN (-) HFpEF and HTN (+) HFpEF exhibited increases in myocyte CSA over referent control although only HTN (+) HFpEF exhibited significant increases in fibrillar collagen content. No significant changes in proliferation or αSMA was detected in HTN (-) HFpEF or HTN (+) HFpEF cultures versus referent control. Significant increases in production of collagen I was detected in HF (-) HFpEF fibroblasts, whereas significant decreases in MT1-MMP levels were measured in HTN (+) HFpEF cells. We conclude that epicardial biopsies provide a viable source for primary fibroblast cultures and that phenotypic differences are demonstrated by HTN (-) HFpEF and HTN (+) HFpEF cells versus referent control.

Indexed as

AgedBiomarkersCase-Control StudiesCell ProliferationCells, CulturedFemaleFibroblastsFibrosisHeart FailureHeart VentriclesHumansHypertensionMaleMiddle AgedMyocardiumPrognosisBiomarkers

Identifiers

PMID35015787
PMCPMC8752005
OpenAlexW4205356420

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.